CTLA4 and neoplasm: In addition, increased expression of the ligands for checkpoint inhibitors, such as PD1, CTLA4, TIM3, TIGIT, CD96, KLRG-1, and LAG3, on the tumor cells attenuates antitumor activity of NK cells [114].